Invention Grant
- Patent Title: Nasal drug products and methods of their use
-
Application No.: US15268066Application Date: 2016-09-16
-
Publication No.: US10085937B2Publication Date: 2018-10-02
- Inventor: Fintan Keegan , Robert Gerard Bell , Roger Crystal , Michael Brenner Weiss
- Applicant: Adapt Pharma Limited , Opiant Pharmaceuticals
- Applicant Address: IE Dublin US CA Santa Monica
- Assignee: ADAPT PHARMA LIMITED,OPIANT PHARMACEUTICALS
- Current Assignee: ADAPT PHARMA LIMITED,OPIANT PHARMACEUTICALS
- Current Assignee Address: IE Dublin US CA Santa Monica
- Agency: Harness, Dickey & Pierce, P.L.C.
- Main IPC: A61M31/00
- IPC: A61M31/00 ; A61M5/00 ; A61F13/00 ; A61K31/56 ; A61K9/00 ; A61K31/485 ; A61K9/08 ; A61K47/18 ; A61M11/00 ; A61K47/02 ; A61M15/08
Abstract:
Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
Public/Granted literature
- US20170071851A1 NASAL DRUG PRODUCTS AND METHODS OF THEIR USE Public/Granted day:2017-03-16
Information query
